Atomo Diagnostics (ASX:AT1) Total Operating Expense: A$7.89 Mil (TTM As of Dec. 2025)


What is Atomo Diagnostics Total Operating Expense?

Atomo Diagnostics ASX:AT1 +5.88% Total Operating Expense is A$7.89 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Atomo Diagnostics's Total Operating Expense for the six months ended in Dec. 2025 was A$3.70 Mil. Atomo Diagnostics's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$7.89 Mil.

Atomo Diagnostics Total Operating Expense Related Terms

Atomo Diagnostics Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Atomo Diagnostics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atomo Diagnostics Total Operating Expense Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Operating Expense
Get a 7-Day Free Trial 9.93 12.72 11.88 8.77 8.38

Atomo Diagnostics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.59 4.17 4.19 4.19 3.70

Atomo Diagnostics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$7.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of A$7.89 Mil mean?
Atomo Diagnostics (ASX:AT1) has a Total Operating Expense of A$7.89 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Atomo Diagnostics and its competitors.
Is Atomo Diagnostics' Total Operating Expense too high?
Atomo Diagnostics' current Total Operating Expense is A$7.89 Mil.
How does Atomo Diagnostics' Total Operating Expense compare to ABT and SYK?
Atomo Diagnostics' Total Operating Expense of A$7.89 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Atomo Diagnostics and its competitors. Atomo Diagnostics's current Total Operating Expense is A$7.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atomo Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Atomo Diagnostics (ASX:AT1) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.02 — trading 10% below its estimated fair value. The current Total Operating Expense is A$7.89 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Atomo Diagnostics (ASX:AT1), the current Total Operating Expense is A$7.89 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atomo Diagnostics Business Description

Address 3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.